Alopecia Areata: How to Recognise It and Treatment Options

You part your hair and discover a round, smooth-looking bare patch that you had not noticed before. Perhaps your hairdresser or a relative spotted it. You do not have to assume the worst: alopecia areata is an immune-mediated inflammatory condition that may affect a small area, and hair sometimes grows back without treatment. But a photo or a circular patch alone cannot establish the diagnosis. A dermatologist can distinguish it from fungal infection, trauma, traction-related hair loss and scarring disease; those conditions require different management.

In alopecia areata, immune activity interferes with hair follicles. Unlike scarring alopecia, typical patches do not destroy the follicle through scarring, so regrowth remains possible. The condition is not contagious and is not a sign of poor hair care. Its course is unpredictable: one patch may fill in, or others may appear; eyebrows, eyelashes and much of the scalp can become involved. Stress or diet should not be presented as the sole proven cause for an individual without careful assessment.

How can you tell whether it is really alopecia areata?

The areas are often round or oval, with fairly calm-looking skin. Short broken hairs may be seen at an edge, and nails sometimes develop small pits or unevenness. Tingling is possible, but marked pain, pus, thick crusts or inflammation require an assessment for other diagnoses. Patches can occur beyond the scalp. Loss of all scalp hair is called alopecia totalis; loss of scalp and body hair is alopecia universalis. A single patch does not mean that either outcome will necessarily follow.

The dermatologist will ask when the patches appeared, how quickly they are changing, family history, other illnesses and medicines. They may examine the scalp, eyebrows, lashes and nails, and use trichoscopy, an examination under magnification, to look for characteristic shaft and scalp signs. Targeted testing or occasionally a small scalp biopsy may be indicated if the diagnosis is uncertain. There is no compulsory battery of vitamin, hormone or immune tests for every person. Buying an “immune system check” does not replace clinical assessment.

What you notice	What must be differentiated	Why it matters
A smooth round patch without obvious irritation	Alopecia areata and other non-scarring causes	Observation or local therapy may be an option once the diagnosis is confirmed
Scale, broken hairs, itch or inflammation	Fungal infection of the scalp	This calls for specific fungal testing and treatment, not a generic hair-growth stimulant
Redness around hairs, pain, pustules or absent follicular openings	Inflammatory scarring alopecias	Timely investigation matters because follicle loss may become permanent
Tight hairstyles and thinning near the hairline	Traction alopecia	Removing the repeated tension is the first priority
Diffuse shedding after childbirth, illness or major weight loss	Telogen effluvium, possibly alongside another condition	The treatment path differs from immune-mediated patch loss

When is observation reasonable, and when should treatment begin?

With one or two small, recently developed patches, observation with a clinician may be a legitimate choice because spontaneous regrowth occurs. Nobody can predict with certainty whether all hairs will return or how long it might take. Waiting is not neglect when the diagnosis is clear, review dates are agreed and you know which changes call for earlier reassessment. Growing or new patches, eyebrow or eyelash loss, a long disease history or a major impact on daily life make discussion of active treatment particularly important.

Severity is about more than the percentage of scalp involved. Rate of loss, skin symptoms, age, other conditions, pregnancy or plans for it, past treatment and personal distress all affect decisions. Clinicians may use the SALT score to measure the area of scalp loss and other assessments that include brows, lashes and quality of life. These scores guide medical choices; they are not a rating of your appearance.

Which treatments have the strongest support?

Topical corticosteroids are anti-inflammatory medicines applied to affected areas; the strength and duration are prescribed according to the individual. Corticosteroid injections into patches can help some adults with limited disease, but may require repeated visits and cause pain, local skin thinning or pigmentation change. Minoxidil is sometimes used as an adjunct to support regrowth. It does not address the underlying autoimmune inflammation and should not be confused with a replacement for the main treatment. Never self-inject medication or use potent topical steroids for prolonged periods without supervision.

Situation	Options a dermatologist may discuss	Important trade-off
A few limited patches	Monitoring; prescribed topical corticosteroids; sometimes intralesional steroid injections in adults	Injection pain, local atrophy or pigmentation changes; the response varies
A child or a sensitive site	Tailored topical treatment with careful follow-up	Age, the area involved and medicine-specific restrictions matter
Extensive or severe disease	Specialist systemic therapy, including appropriately authorised oral JAK inhibitors where available	Screening, ongoing monitoring and serious risk assessment are required; access differs by country
Poor response or a contraindication	Other specialist immunomodulatory regimens or contact immunotherapy	Evidence and adverse effects differ; some regimens are outside a drug's authorised indication
Wanting to make hair loss less visible now	A wig, hair topper, scarf, eyebrow makeup or other camouflage	Can improve comfort but does not treat the immune inflammation

For severe alopecia areata, some medicines inhibit Janus kinase (JAK) signalling, an immune pathway. In the EU, ritlecitinib (Litfulo) is indicated for severe alopecia areata from age 12 onward; baricitinib is authorised there for severe disease in adults. In July 2026, the EU also authorised upadacitinib (Rinvoq), another medicine in this group, for severe alopecia areata in adults and adolescents aged 12 years or older. US approvals and age thresholds may differ and change over time. Regulatory authorisation in the EU or US does not establish registration, supply or prescribing arrangements in Armenia. One small patch does not automatically warrant systemic immune-suppressing medicine.

Why are tablets for severe disease not ordinary “hair vitamins”?

Some patients taking JAK inhibitors develop substantial regrowth, sometimes including eyebrows and eyelashes; others see limited benefit. Response is judged over time, and hair can be lost again when treatment stops. These drugs carry important warnings, including serious infections, blood clots, cardiovascular events and malignancy. Those outcomes do not happen to everyone, but personal risk evaluation is essential.

Before prescribing, the specialist considers infection history, tuberculosis and hepatitis risks, other illnesses, medicines, vaccination status and laboratory results as required by the exact drug's prescribing information. Monitoring continues during treatment. Pregnancy and breastfeeding involve major restrictions; the EU information for Litfulo explicitly contraindicates use during both. Tell your clinician before treatment if pregnancy is planned. Do not start, stop or change an immune-modifying medicine independently.

During systemic therapy, high fever or signs of serious infection, sudden shortness of breath, chest pain, swelling of one leg or sudden unusual neurological symptoms require urgent medical assessment; severe symptoms call for emergency services. These are warning signs, not a way to diagnose a complication online. Report non-emergency problems such as a rash, digestive upset or headache to the prescriber rather than changing the dose yourself.

What does recovery look like, and when might you feel comfortable in public?

There is no single recovery period “after the procedure” for alopecia areata: the main waiting period follows the hair-growth cycle. Even effective treatment may not show changes the following week. Early new hairs may be short, soft or paler than usual. Evaluating regrowth takes follow-up over months, and neither final density nor durability is guaranteed. Photos of the same area in the same light are more informative than examining each hair every day.

An ordinary scalp examination or trichoscopy usually causes no social downtime. Steroid injections may leave brief soreness or visible needle marks; follow the clinician's aftercare advice. Topical products can irritate, while specialist contact immunotherapy deliberately produces a local inflammatory reaction and needs monitoring. These are not equivalent to a beauty treatment that can promise no side effects. Before a major event, ask what the patch will look like immediately after your specific treatment, as well as how long regrowth may take.

While waiting, you might choose a comfortable scarf, wig, gentle hairstyle or brow makeup. If eyelashes are lost, ask about protecting the eyes from dust and dryness. Avoid irritating exfoliants, tight hairstyles, scratching and self-administered scalp injections. Psychological support is a valid part of care if appearance-related distress is significant, regardless of the patch's size. You do not need to prove that the loss is “serious enough” to deserve support.

What should not replace treatment?

Shampoos, “scalp detox”, mesotherapy, microneedling, platelet-rich plasma and cosmetic lasers are not established universal treatments for autoimmune alopecia areata. Some are being studied as adjuncts, but the quality of evidence varies and current professional guidance does not support treating them as equivalent to established care. Hair transplantation is generally not the initial answer to active alopecia areata because the immune condition may affect transplanted hairs; controlling disease activity matters first. Guaranteed regrowth after a fixed number of sessions without diagnosis is a reason to seek independent advice.

A balanced diet supports general health, and a documented deficiency can warrant appropriate treatment. But megadoses of vitamins without an identified deficiency may bring risks rather than benefit. You should not be blamed for alopecia areata because of hair-care habits or “the wrong emotions”. Its biology is more complex; that distinction matters when making sensible treatment decisions.

A first-appointment plan without unrealistic promises

Arrange an earlier assessment if a patch is growing quickly, multiple new patches appear, or there is pain, crusting, pus, marked redness or loss of visible follicular openings. These may point to a different disease that needs timely treatment. With a stable, small patch, you can reasonably ask about observation before starting medicine. The goal of the visit is not necessarily to obtain the strongest drug straight away; it is to understand the diagnosis, the uncertainty of its course and your options.

Photograph new patches under similar lighting; note when they appeared and whether they are changing.
Report itching, pain, scale, nail changes, eyebrow or eyelash loss, medical conditions and medicines.
Ask for the leading diagnosis and signs arguing against it, and whether tests or a biopsy are needed.
Ask whether the disease is active and which changes require earlier review.
Compare observation, local treatment and—only when disease severity warrants it—systemic treatment, including risks and monitoring.
Discuss safe options for looking and feeling comfortable now while you wait for any regrowth.

Frequently asked questions

May I dye my hair while I have a patch?

If the scalp is calm, the answer depends on skin condition and product tolerance. If the area is irritated, inflamed or being treated with a therapy that deliberately causes contact inflammation, discuss chemical processing with the dermatologist first.

Can another patch appear after my hair grows back completely?

Yes. Regrowth does not mean the disease can never recur. A new patch warrants another consultation, even if the previous episode settled without treatment.

Should symptom-free family members have preventive tests?

Usually, family history alone is not a reason for screening scans or treatment. Relatives should seek medical advice if they develop changes in their hair or scalp.